We are live on ! Find out more
SG

StepStone Group Portfolio holdings

AUM $207M
1-Year Est. Return 12.33%
This Fund
S&P 500
This Quarter Est. Return
+50.13%
1 Year Est. Return
-12.33%
3 Year Est. Return
+92.06%
5 Year Est. Return
+17.44%
10 Year Est. Return
+217.33%
AUM
$114M
AUM Growth
-$160M
Cap. Flow
-$182M
Cap. Flow %
-158.83%
Top 10 Hldgs %
98.29%
Holding
18
New
4
Increased
Reduced
1
Closed
4

Top Buys

Rank Stock Value
1
OKUR
OnKure Therapeutics
OKUR
+$7.45M
2
COIN icon
Coinbase
COIN
+$3.37M
3
METC icon
Ramaco Resources Class A
METC
+$43K

Top Sells

Rank Stock Value
1
DNB
Dun & Bradstreet
DNB
+$152M
2
RBLX icon
Roblox
RBLX
+$20.7M
3
RKLB icon
Rocket Lab Corp
RKLB
+$18.8M
4
FRSH icon
Freshworks
FRSH
+$1.63M
5
NEUE
NeueHealth
NEUE
+$11.1K

Sector Composition

Rank Sector Weight
1 Financials 49.73%
2 Healthcare 23.69%
3 Technology 14.3%
4 Consumer Discretionary 10.47%
5 Industrials 0.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ML
1
DELISTED
MoneyLion Inc.
ML
$53.6M 46.85%
622,931
PATH icon
2
UiPath
PATH
$6.23B
$16.4M 14.3%
1,286,527
TRDA icon
3
Entrada Therapeutics
TRDA
$267M
$13.2M 11.51%
761,277
DKNG icon
4
DraftKings
DKNG
$12.3B
$12M 10.47%
321,804
OKUR
5
OnKure Therapeutics
OKUR
$166M
$4.23M 3.7%
+491,938
New +$7.45M
NEUE
6
DELISTED
NeueHealth
NEUE
$3.9M 3.41%
525,247
-2,103
-0.4% -$11.1K
PHAT icon
7
Phathom Pharmaceuticals
PHAT
$875M
$3.43M 3%
422,085
COIN icon
8
Coinbase
COIN
$42.3B
$3.3M 2.88%
+13,281
New +$3.37M
HLVX
9
DELISTED
HilleVax
HLVX
$1.71M 1.5%
826,569
VCSA
10
DELISTED
Vacasa, Inc. Class A Common Stock
VCSA
$722K 0.63%
147,261
TNYA icon
11
Tenaya Therapeutics
TNYA
$182M
$661K 0.58%
462,163
GROV icon
12
Grove Collaborative
GROV
$45.8M
$529K 0.46%
380,383
METC icon
13
Ramaco Resources Class A
METC
$790M
$38.9K 0.03%
+3,875
New +$43K
DNB
14
DELISTED
Dun & Bradstreet
DNB
-13,219,351
Closed -$152M
FRSH icon
15
Freshworks
FRSH
$3.03B
-141,735
Closed -$1.63M
RBLX icon
16
Roblox
RBLX
$38.7B
-466,666
Closed -$20.7M
RKLB icon
17
Rocket Lab Corp
RKLB
$42.1B
-1,936,599
Closed -$18.8M

Similar funds

StepStone Group's Q4 2024 Portfolio in Review

As of Q4 2024, StepStone Group held 18 positions worth $114M, down 58% from $274M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

StepStone Group withdrew a net $182M in Q4 2024, closing 4 positions and reducing 1 holding. Its most notable exit was Dun & Bradstreet, an estimated $152M position sold in full.

By sector, the portfolio is most concentrated in Financials at 50% of assets, down from 65% a quarter earlier, followed by Healthcare and Technology.

Against the trend, StepStone Group opened a new position in OnKure Therapeutics worth $4.23M.

  • StepStone Group's largest Q4 2024 buy was OnKure Therapeutics: 491,938 shares worth $4.23M.
  • StepStone Group's biggest Q4 2024 reduction was NeueHealth, cutting an estimated $11.1K.
  • StepStone Group fully exited Dun & Bradstreet in Q4 2024, selling an estimated $152M.
  • StepStone Group's ten largest holdings make up 98% of its $114M portfolio in Q4 2024.
  • StepStone Group opened 4 new positions and closed 4 in Q4 2024.
  • StepStone Group's portfolio value fell 58% quarter-over-quarter to $114M.

Based on StepStone Group's 13F filing for Q4 2024, filed 13 Feb 2025.